Accessibility statement
Homepage
Sitemap
Search
Contact
Print
Value through Innovation
Help
jump to main navigation
jump to content
Home
Contact
Site Map
Search
main navigation
jump to content
to meta navigation
News Centre
Corporate Profile
Global Activities
Research & Development
Clinical Trials
Products
Industrial Customer
Careers
page content
jump to main navigation
to meta navigation
Top Links
About us
Take-away info
Financial Highlights
Products
Corporate Image Video
Our Vision
Corporate Responsibility
Licensing & Partnering
Indication Areas
Benign Prostate Hyperplasia
COPD
HIV/AIDS
Hypertension
Parkinson Disease
Restless Legs Syndrome
Stroke
further areas
Consumer Health Care
Bisolvon®
Buscopan®
Dulcolax®
Mucosolvan®
Pharmaton®
further products
Our Businesses
Prescription Medicines
Consumer Health Care
Biopharmaceuticals
Pharma Chemicals
Pharmaceuticals Production
Animal Health
News Resources
Press & Information Packs
Conference Calendar
Media Pool
Annual Report
Publication Download
Information & Dialogue
FAQs - Get the answers
Contact - Get in touch
RSS
Follow us on Twitter
Latest Press Releases
26.07.2010
European Committee for Medicinal Products for Human Use (CHMP) adopts Positive Opinion for TWYNSTA®, Boehringer Ingelheim’s new single pill combination hypertension treatment
- For non-US and non-UK Healthcare Media
22.07.2010
VERxVE study demonstrates efficacy and safety of 400mg once daily nevirapine (Viramune®) extended release (NVP XR) formulation
08.07.2010
First PCV-2 / Mycoplasma hyopneumoniae vaccine combination registered in the European Union
Further press releases
VERxVE Study Results
More about Viramune® (nevirapine)
Oncology Website
Learn more
Linagliptin Phase III Data
View the Webcast
Biopharmaceuticals
Read more
Pharma Chemicals
Read more
No flash player detected. For optimized usage of this website your browser should support shockwave flash. For downloading see Macromedia Flash Player
back to top
Our Global Activities
Our Countries A-Z
Argentina
Austria
Australia
Bahrain
Belarus
Belgium
Bosnia and Herzegovina
Brazil
Bulgaria
Canada
Chile
China
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Ecuador
Egypt
Estonia
Ethiopia
Finland
France
Germany
Germany Headquarters
Greece
Ghana
Hong Kong
Hungary
India
Indonesia
Iraq
Irland
Israel
Italy
Japan
Jordan
Kenya
Kuweit
Latvia
Lebanon
Libya
Lithuania
Macedonia
Malawi
Malaysia
Malta
Mauritius
Mexico
Montenegro
The Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Peru
The Philippines
Poland
Portugal
Quatar
Romania
Russia
Saudi Arabia
Seychelles
Serbia
Singapore
Slovakia
Slovenia
Somalia
South Africa
South Korea
Spain
Sudan
Sweden
Switzerland
Syria
Taiwan
Tanzania
Thailand
Turkey
USA
Uganda
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Venezuela
Vietnam
Yemen
for US residents
Bookmarking Services
Digg
Del.icio.us
Google
Facebook
Technorati
Follow Boehringer Ingelheim
Follow us on Twitter